Search For "phase ii"
CSIR begins clinical trials for Niclosamide drug as Covid-19 treatment
Updated : 4 years, 11 months ago IST
New Delhi [India], June 6 (ANI): Council of Scientific and Industrial Research (CSIR) along and Laxai Life Sciences Pvt. Ltd. on Sunday initiated Phase-II clinical trial for anti-helminitic drug Niclosamide for treatment of Covid-19.
Read More
Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in
Updated : 4 years, 11 months ago IST
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Read More
COVID-19: MSN Laboratories initiates Phase III clinical trial of Molnupira
Updated : 4 years, 12 months ago IST
New Delhi [India], May 26 (ANI): MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of COVID-19 in India.
Read More
Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for
Updated : 4 years, 12 months ago IST
Hyderabad (Telangana) [India], May 25 (ANI/PRNewswire): Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild to Moderate Covid-19 patients.
Read More
Drugs manufacturer from Hyderabad on overdrive
Updated : 5 years ago IST
Hyderabad (Telangana) [India], May 19 (ANI/PNN): Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild and Moderate Covid-19 symptoms.
Read More
Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12
Updated : 5 years ago IST
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
Read More
Treat PIL seeking expansion of FAME scheme, inclusion of hydrogen-powered
Updated : 5 years ago IST
New Delhi [India], May 18 (ANI): The Delhi High Court on Tuesday directed the Central Government to treat as representation a Public Interest Litigation (PIL) seeking directions for expansion of benefits and incentives under phase II of faster adoption and manufacturing of electric vehicles
Read More
COVID-19: More than 42 lakh beneficiaries of age group 18-44 vaccinated in
Updated : 5 years ago IST
New Delhi [India], May 15 (ANI): Since the beginning of Phase III of the vaccination drive in India, more than 42 lakh beneficiaries of age group 18-44 have been given the first dose of COVID-19 vaccine, the Ministry of Health and Family Welfare said on Saturday.
Read More
Cabinet approves free foodgrain under PMGKAY for 2 months
Updated : 5 years ago IST
New Delhi [India], May 5 (ANI): The Union Cabinet on Wednesday approved the allocation of additional foodgrain to NFSA beneficiaries under Pradhan Mantri Garib Kalyan Anna Yojana (Phase III) for a period of two months -- May and June 2021.
Read More
Over 4 lakh beneficiaries of age group 18-44 vaccinated so far in Phase II
Updated : 5 years ago IST
New Delhi [India], May 4 (ANI): More than four lakh beneficiaries, belonging to the age group of 18-44 years have been vaccinated till date since the third phase of the vaccination drive commenced on Saturday, informed the government on Tuesday morning.
Read More
COVID-19: India to begin vaccination drive for 18+ from today amid vaccine
Updated : 5 years ago IST
New Delhi [India], May 1 (ANI): India will start the vaccination drive for those in the 18-44 age bracket from Saturday as the country continues to battle the second wave of COVID-19.
Read More
Tripura needs 32 lakh Covid vaccine doses to cover 100 pc population betwe
Updated : 5 years ago IST
Agartala (Tripura) [India], April 30 (ANI): Tripura needs around 32 lakh vaccine doses for 100 per cent vaccination residents of the state between the age group of 18 years and 44 years, said Dr Siddharth Shiv Jaiswal, state Director, National Health Mission (NHM), ahead of Phase III of the
Read More